InMed Pharmaceuticals (INM) Current Leases (2020 - 2026)
InMed Pharmaceuticals (INM) posted quarterly Current Leases of $389381.0 for Q1 2026, down 9.29% year-over-year from $429247.0 in Q1 2025, and down 4.59% quarter-over-quarter from $408122.0 in Q4 2025.
InMed Pharmaceuticals (INM) Current Leases (2020 - 2026) Analysis & Trends
InMed Pharmaceuticals' Current Leases history runs 7 years deep, the most recent figure standing at $389381.0 for Q1 2026.
- In Q1 2026, Current Leases fell 9.29% year-over-year to $389381.0; the TTM figure through Mar 2026 stood at $389381.0 (down 9.29% YoY), while the FY2025 annual figure was $435507.0, up 37.04% from the prior year.
- Current Leases for Q1 2026 stood at $389381.0, down from $408122.0 in the prior quarter.
- The five-year high for Current Leases was $435507.0 in Q2 2025, with the low at $292998.0 in Q3 2023.
- The 5-year median for Current Leases is $404276.0 (2022), against an average of $392556.5.
- The sharpest annual moves came in 2022 and 2023: Current Leases surged 407.38% in 2022, then declined 27.5% in 2023.
- InMed Pharmaceuticals' Current Leases stood at $414307.0 in 2022, then decreased by 12.1% to $364190.0 in 2023, then gained by 15.25% to $419711.0 in 2024, then dropped by 2.76% to $408122.0 in 2025, then dropped by 4.59% to $389381.0 in 2026.
- Business Quant data shows INM's Current Leases at $389381.0 in Q1 2026, $408122.0 in Q4 2025, and $424765.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | InMed Pharmaceuticals | 6.44 Mn | 1.20 Mn | - | 389,381.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 389,381.00 |
| Dec 31, 2025 | 408,122.00 |
| Sep 30, 2025 | 424,765.00 |
| Jun 30, 2025 | 435,507.00 |
| Mar 31, 2025 | 429,247.00 |
| Dec 31, 2024 | 419,711.00 |
| Sep 30, 2024 | 424,260.00 |
| Jun 30, 2024 | 317,797.00 |
| Mar 31, 2024 | 345,545.00 |
| Dec 31, 2023 | 364,190.00 |
| Sep 30, 2023 | 292,998.00 |
| Jun 30, 2023 | 375,713.00 |
| Mar 31, 2023 | 423,574.00 |
| Dec 31, 2022 | 414,307.00 |
| Sep 30, 2022 | 404,163.00 |
| Jun 30, 2022 | 404,276.00 |
| Mar 31, 2022 | 399,904.00 |
| Dec 31, 2021 | 391,805.00 |
| Sep 30, 2021 | 82,232.00 |
| Jun 30, 2021 | 80,483.00 |